Lindbrook Capital »

Denali Therapeutics shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.4k 314 20.52
2023-12-31 $14k 646 21.46
2023-09-30 $4.9k 239 20.63
2023-06-30 $19k 642 29.51
2023-03-31 $11k 454 23.04
2022-12-31 $9.9k 355 27.81
2022-09-30 $9.0k 277 32.49
2022-06-30 $7.0k 223 31.39
2022-03-31 $7.0k 204 34.31
2021-12-31 $27k 611 44.19
2021-03-31 $2.0k 34 58.82